Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

PARÍS--(BUSINESS WIRE)--One Biosciences, empresa pionera en perfiles tumorales unicelulares de grado clínico que combina biotecnología e inteligencia computacional, ha anunciado hoy que ha recibido financiación a través de una subvención BOOST del Paris-Saclay Cancer Cluster (PSCC) para desarrollar el primer ensayo unicelular destinado a terapias oncológicas basadas en conjugados anticuerpo-fármaco (ADC). El rápido crecimiento de los ADC hace cada vez más necesarias estrategias de biomarcadores...

PARIJS--(BUSINESS WIRE)--One Biosciences, een techbio-bedrijf dat baanbrekend werk verricht op het gebied van klinisch toepasbaar single-cell tumorprofilering, heeft vandaag financiële steun aangekondigd via een BOOST-subsidie van het Paris-Saclay Cancer Cluster (PSCC) voor de ontwikkeling van de eerste single-cell assay voor antilichaam-geneesmiddelconjugaten (ADC)-therapieën in de oncologie. De snelle groei van ADC's leidt tot een toenemende vraag naar geavanceerdere biomarkerstrategieën. Doo...

PARIS--(BUSINESS WIRE)--One Biosciences, ein Techbio-Unternehmen, das Pionierarbeit im Bereich der klinischen Einzelzell-Tumorprofilierung leistet, gab heute bekannt, dass es im Rahmen eines BOOST-Zuschusses des Paris-Saclay Cancer Cluster (PSCC) finanzielle Unterstützung für die Entwicklung des ersten Einzelzell-Assays für Antikörper-Wirkstoff-Konjugate (ADC) in der Onkologie erhält. Das rasante Wachstum im Bereich der ADCs treibt die Nachfrage nach ausgefeilteren Biomarker-Strategien voran. D...

PARIS--(BUSINESS WIRE)--One Biosciences, une entreprise de type techbio pionnière dans le profilage tumoral unicellulaire de qualité clinique, a annoncé aujourd’hui avoir obtenu un soutien financier dans le cadre d’une subvention BOOST du Pôle Cancer Paris-Saclay (PSCC) afin développer le premier essai unicellulaire pour les thérapies ADC en oncologie. La croissance rapide des ADC stimule la demande de stratégies de biomarqueurs plus sophistiquées. En rendant compte de la complexité tumorale à...

PARIGI--(BUSINESS WIRE)--One Biosciences, azienda specializzata in biotecnologia, pioniera nella profilazione tumorale a singole cellule di livello clinico, oggi ha annunciato il supporto finanziario attraverso un finanziamento BOOST del Paris-Saclay Cancer Cluster (PSCC) per sviluppare la prima analisi a singole cellule per terapie a base di anticorpi coniugati con farmaci (ADC) in oncologia. La rapida ascesa degli ADC è alla base della domanda di strategie più sofisticate basate sui biomarcat...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 22.06.2026 H2O LN IE000Q8F0M81 600,002.00 USD 12,025,526.21 20.043  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 22.06.2026 FBTU.LN IE00BL0L0H60 400,002.00 USD 11,257,950.85 28.145  ...

MIAMI BEACH, Fla.--(BUSINESS WIRE)--LQR House Inc. (the “Company” or “LQR House”) (NASDAQ:YHC) today confirmed that it is in advanced negotiations with ByteDance regarding a strategic relationship spanning ByteDance’s artificial intelligence vertical, the family of enterprise AI models and infrastructure built by one of the world’s largest technology companies. These discussions are a continuation of the strategy LQR House set out when it acquired and consolidated Fusion Five Continents Securit...